Vericel (VCEL) Net Cash Flow Growth (1y) (2012 - 2026)
Vericel (VCEL) Net Cash Flow Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -88.82% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 301.06% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 453.08% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -125.22% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Vericel | 2.30 Bn | 2.15 Bn | 49.27 Mn | 272.21% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 272.21% |
| Dec 31, 2025 | -102.12% |
| Sep 30, 2025 | 461.03% |
| Jun 30, 2025 | -83.82% |
| Mar 31, 2025 | 66.86% |
| Dec 31, 2024 | 344.75% |
| Sep 30, 2024 | -143.19% |
| Jun 30, 2024 | -43.09% |
| Mar 31, 2024 | -249.75% |
| Dec 31, 2023 | 123.36% |
| Sep 30, 2023 | 327.94% |
| Jun 30, 2023 | 2,174.18% |
| Mar 31, 2023 | 260.75% |
| Dec 31, 2022 | -202.70% |
| Sep 30, 2022 | 6.66% |
| Jun 30, 2022 | 106.18% |
| Mar 31, 2022 | -127.30% |
| Dec 31, 2021 | 239.34% |
| Sep 30, 2021 | 123.12% |
| Jun 30, 2021 | -163.42% |